Moderna, Inc. (MRNA) Operating income 2016–2025
Moderna, Inc. (MRNA) annual operating income history from SEC filings — each fiscal year as reported.
-$3.1BFY2025 · since FY2016: -$223.8M → -$3.1B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$3.1B | +22.1% |
| FY2024 | -$3.9B | +6.9% |
| FY2023 | -$4.2B | -145.0% |
| FY2022 | $9.4B | -29.2% |
| FY2021 | $13.3B | +1842.6% |
| FY2020 | -$763.0M | -39.7% |
| FY2019 | -$546.0M | -32.1% |
| FY2018 | -$413.3M | -53.4% |
| FY2017 | -$269.4M | -20.4% |
| FY2016 | -$223.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice